3 recruiting, 1 not yet recruiting, 1 unknown. 4 Phase 1, 4 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 4 | Recruiting 2, Not yet recruiting 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
Follow phase II: new trials by email Literature Review of phase II trials Research Report on phase II
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors Phase I dose escalation, Phase I: Dose Expansion, phase II - Advanced Solid Tumor Cancer | Phase 1 / Phase 2 | Not yet recruiting | Suzhou Genhouse Bio Co., Ltd. | 152 | 2026-02-24 | 2026-03-03 |
| A Study of GQ1010 in Subjects With Advanced Solid Tumors Dose Escalation, Dose Expansion1, Dose Expansion2 - Advanced Malignant Solid Tumors | Phase 1 / Phase 2 | Recruiting | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 260 | 2024-05-23 | 2025-02-10 |
| Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia Phase I, Phase II - Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 / Phase 2 | Unknown | KK Women's and Children's Hospital | 48 | 2022-07-18 | 2023-03-09 |
| Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer Phase I, Phase II - Breast Cancer | Not applicable | Recruiting | European Institute of Oncology | 79 | 2021-07-31 | 2024-08-05 |
| A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies AMXI-5001:Dose Escalation Phase I, AMXI-5001:Dose Expansion Phase II - Advanced Malignant Neoplasm, Breast Cancer | Phase 1 / Phase 2 | Recruiting | AtlasMedx, Incorporated | 122 | 2020-08-12 | 2025-05-01 |
Breast Neoplasms (2) · Disease Progression (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Prostatic Neoplasms (1)
AtlasMedx, Incorporated (1) · European Institute of Oncology (1) · GeneQuantum Healthcare (Suzhou) Co., Ltd. (1) · KK Women's and Children's Hospital (1) · Suzhou Genhouse Bio Co., Ltd. (1)
China (2) · Italy (1) · Singapore (1) · United States (1)
Maria Cristina Leonardi (1) · Michaela Seng, MD (1) · Pamela Munster, MD (1) · Wing Hang Leung, MD PhD (1)